Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC01
- Pharmacological subgroupC01D
- Chemical subgroupC01DA
- Chemical substanceC01DA02Glyceryl trinitrate
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 63 registrations
- Mylan-Nitro Patch 0.20.2 MG / HOUR · Patch (Extended-Release) · Mylan Pharmaceuticals Ulc
- Mylan-Nitro Patch 0.40.4 MG / HOUR · Patch (Extended-Release) · Mylan Pharmaceuticals Ulc
- Mylan-Nitro Patch 0.60.6 MG / HOUR · Patch (Extended-Release) · Mylan Pharmaceuticals Ulc
- Mylan-Nitro Patch 0.80.8 MG / HOUR · Patch (Extended-Release) · Mylan Pharmaceuticals Ulc
Spain
AEMPS · 30 registrations
At a glance
- ATC code
- C01DA02
- ATC group
- Cardiovascular system
- Registers
- 10
- Historical lists
- 2
- Registrations
- 180
- With their own page
- 109
- Companies
- 95
All medicines with Nitroglycerin
Human medicines from every register that match Nitroglycerin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
186 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Nitroglycerin | United States | 0.1MG/HR, 0.2MG/HR, 0.4MG/HR … | film, extended release | Marketed | Mylan Technologies |
| Nitroglycerin | United States | 10MG/ML, 5MG/ML, 5MG/ML | injectable | Marketed | Hospira |
| Nitroglycerin | United States | 0.4% | ointment | Marketed | TP Anda Holdings |
| Nitroglycerin | United States | 2% | ointment | Marketed | Encube |
| Nitroglycerin | United States | 0.4MG/SPRAY | spray, metered | Marketed | Padagis Israel |
| Nitroglycerin | United States | 0.3MG, 0.4MG, 0.6MG | tablet | Marketed | Rubicon Research |
| Nitroglycerin in Dextrose 5% | United States | 0.1MG/ML, 10MG/100ML, 20MG/100ML … | injectable | Marketed | Hospira |
| Nitroglycerin Injection USP | Canada | 50 MG / 10 ML | Solution | Authorised | Mont-Pharma INC |
| Nitroglycerin in 5% Dextrose Inj.-200MCG/MLCombination | Canada | 5 G / 100 ML + 20 MG / 100 ML | Solution | Marketed | Baxter Corporation |
| Nitroglycerin in 5% Dextrose Inj.-400MCG/MLCombination | Canada | 5 G / 100 ML + 40 MG / 100 ML | Solution | Marketed | Baxter Corporation |
| Nitroglycerine Macure 1 mg/ml oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | Macure Healthcare Limited | |
| Nitroglycerine-hameln 1 mg/ml, oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | hameln pharma gmbh | |
| Nitroglycerine Teva 5 mg/24u, pleister voor transdermaal gebruik | Netherlands | Pleister voor transdermaal gebruik | Authorised | Teva Nederland B.V. | |
| Nitroglycerine Teva 10 mg/24u, pleister voor transdermaal gebruik | Netherlands | Pleister voor transdermaal gebruik | Authorised | Teva Nederland B.V. | |
| Nitroglycerine Teva 15 mg/24u, pleister voor transdermaal gebruik | Netherlands | Pleister voor transdermaal gebruik | Authorised | Teva Nederland B.V. | |
| Apo-Nitroglycerin | Canada | 0.4 MG / ACT | Metered-Dose Pump | Not marketed | Apotex INC |
| Nitroglycerine Inj F.T.V.5 ML 25 MG | Saudi Arabia | Authorised | Hospira | ||
| Nitroglycerine Inj F.T.V.50MG-10 ML | Saudi Arabia | Authorised | Hospira | ||
| Nitro-Dur | United States | 0.1MG/HR, 0.2MG/HR, 0.3MG/HR … | film, extended release | Marketed | Uspharma |
| Nitrostat | United States | 0.3MG, 0.4MG, 0.6MG | tablet | Marketed | Viatris |
| Nitromist | United States | 0.4MG/SPRAY | aerosol, metered | Marketed | Evus |
| Nitrolingual Pumpspray | United States | 0.4MG/SPRAY | spray, metered | Marketed | Pohl Boskamp |
| Nitrolingual | United States | 0.4MG/SPRAY | aerosol | Not marketed | Pohl Boskamp |
| Nitrol | United States | 0.8MG/ML | injectable | Not marketed | Rorer |
| Myonit Insta Nitroglycerin Sublingual Tablets USP 0.5MG | Singapore | 0.5mg | tablet | Authorised | Trinity Pharmaceuticals & Food Pte. LTD. |